Search Login Register

Iloprost (Ventavis) Summary

Description: An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.

Also Known As: Ventavis; CoTherix Brand of Iloprost; ZK-36374; ZK 36374; ZK36374 Show All >>

Networked: 854 relevant articles (148 outcomes, 166 trials/studies) for this Drug

Key Diseases for which Iloprost is Relevant

  1. Pulmonary Hypertension (Ayerza Syndrome) : 28 outcomes 29 studies in 180 results
  2. Ischemia : 20 outcomes 22 studies in 115 results
  3. Ulcer : 16 outcomes 11 studies in 61 results
  4. Reperfusion Injury : 11 outcomes 13 studies in 36 results
  5. Pain (Aches) : 11 outcomes 8 studies in 46 results
Show All >>

Drugs Related to Iloprost

  1. Epoprostenol (Prostacyclin)
  2. Alprostadil (Muse)
  3. Prostaglandins
  4. Idiopathic pulmonary hypertension
  5. sildenafil (Viagra)
  6. bosentan (Tracleer)
  7. Nitric Oxide (Nitrogen Monoxide)
  8. Oxygen
  9. Dinoprostone (PGE2)
  10. Diltiazem (Cardizem)
Show All >>

Therapies Related to Iloprost

  1. Intravenous Infusions
  2. Amputation
  3. Cardiopulmonary Bypass (Heart-Lung Bypass)
  4. Decompression
  5. Heart Transplantation (Grafting, Heart)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.